NVIDIA’s chips are inside more than 400 of the 500 most powerful supercomputers on the planet, according to the latest TOP500 list. That means 81% of the world’s fastest machines now rely on the company’s graphics processors to run everything from climate simulations to AI training. The figure cements NVIDIA’s grip on high-performance computing, a market it has been steadily carving out since the early days of GPU-accelerated science.
How the numbers break down
The TOP500 list, which ranks supercomputers by performance twice a year, shows that 418 systems use NVIDIA GPUs. A decade ago that share was barely above 10%. The jump comes as research labs and cloud providers swap traditional CPUs for parallel-processing chips that can handle the massive floating-point math needed for molecular dynamics and deep learning. NVIDIA’s own H100 and older A100 GPUs dominate the current top-end machines.
Dominance in AI and HPC
The overlap between artificial intelligence and traditional supercomputing explains much of the shift. Large language models and scientific simulations both benefit from the same hardware architecture. The company’s CUDA software platform, which lets developers write code that runs on its GPUs, has become the de facto tool kit in both fields. National labs, oil companies, and pharmaceutical firms all rely on it. And while Intel and AMD still supply CPUs for many of these systems, the real horsepower — and the bottleneck — is now almost entirely from NVIDIA.
What this means for competitors
AMD has been trying to break in with its Instinct line, but the latest TOP500 shows only about 30 systems using AMD GPUs. Intel’s Ponte Vecchio and newer Max series have barely dented the list. The challenge isn’t just hardware — it’s the software ecosystem. NVIDIA has spent years building libraries and frameworks that researchers already know, making a switch expensive and risky. That lock-in effect is hard to undo, even with faster chips.
The next TOP500 update is due in November. If current trends hold, NVIDIA’s share could climb even higher. The real question is whether any competitor can offer a combination of performance, programmability, and price that makes labs reconsider.
